Statins and clinical outcome of acute ischemic stroke: A systematic review

International Archives of Medicine

Volumn 3, Issue 1, 2010, Pages

  Lakhan, Shaheen E ^a   Bagchi, Sanjit ^a   Hofer, Magdalena ^a  

^a Global Neuroscience Initiative Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BARTHEL INDEX; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CANCER RISK; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIFFUSION WEIGHTED IMAGING; DISABILITY SEVERITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; EMBASE; FUNCTIONAL STATUS; HEART INFARCTION; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MEDLINE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROSPECTIVE PAYMENT; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RANKIN SCALE; RECURRENT DISEASE; RHABDOMYOLYSIS; RISK REDUCTION; SECONDARY PREVENTION; STABLE ANGINA PECTORIS; STROKE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR DISEASE;

EID: 77957144850     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-3-22     Document Type: Article

References (39)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Scandinavian Simvastatin Survival Study Group, Lancet 1994 344 1383 1389 7968073
2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. FM Sacks MA Pfeffer LA Moye JL Rouleau JD Rutherford TG Cole L Brown JW Warnica JM Arnold CC Wun BR Davis E Braunwald, N Engl J Med 1996 336 1001 1009
3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group, N Engl J Med 1998 339 1349 1357 9841303
4. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. J Shepherd SM Cobbe I Ford CG Isles AR Lorimer PW MacFarlane JH McKillop CJ Packard, N Engl J Med 1995 333 1301 1307 7566020
5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JR Downs M Clearfield S Weis E Whitney DR Shapiro PA Beere A Langendorfer EA Stein W Kruyer AM Gotto Jr, JAMA 1998 279 1615 1622 9613910
6. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial. Heart Protection Study Collaborative Group, Lancet 2002 360 7 22 12114036
7. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. B Fuentes P Martínez-Snchez E Díez-Tejedor, Cerebrovasc Dis 2009 27 Suppl 1 126 33 19342842
8. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Prospective Studies Collaboration S Lewington G Whitlock R Clarke P Sherliker J Emberson J Halsey N Qizilbash R Peto R Collins, Lancet 2007 370 1829 1839 18061058
9. Statins in stroke prevention and carotid atherosclerosis: systematic review and up to-date meta-analysis. P Amarenco J Labreuche P Lavallee PJ Touboul, Stroke 2004 35 2902 2909 15514180
10. Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. GJ Blauw AM Lagaay AH Smelt RG Westendorp, Stroke 1997 28 946 950 9158630
11. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. PR Hebert JM Gaziano KS Chan CH Hennekens, JAMA 1997 278 313 321 9228438
12. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. C Baigent A Keech PM Kearney L Blackwell G Buck C Pollicino,, et al. Lancet 2005 366 1267 1278 16214597
13. High-dose atorvastatin after stroke or transient ischemic attack. P Amarenco J Bogousslavsky A Callahan LB Goldstein M Hennerici AE Rudolph H Sillesen L Simunovic M Szarek KM Welch JA Zivin Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators, N Engl J Med 2006 355 549 559 16899775
14. Favorable outcome of ischemic stroke in patients pretreated with statins. J Martí-Fbregas M Gomis A Arboix A Aleu J Pagonabarraga R Belvís D Cocho J Roquer A Rodríguez MD García L Molina-Porcel J Díaz-Manera JL Martí-Vilalta, Stroke 2004 35 1117 21 15073403
15. Rising statin use and effect on ischemic stroke outcome. SS Yoon J Dambrosia J Chalela M Ezzeddine S Warach J Haymore L Davis AE Baird, BMC Medicine 2004 2 4 7 15035663
16. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. S Greisenegger M Müllner S Tentschert W Lang W Lalouschek, J Neurol Sci 2004 221 5 10 15178206
17. HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome. M Moonis K Kane U Schwiderski BW Sandage M Fisher, Stroke 2005 36 1298 1300 15879346
18. Effect of pretreatment with statins on ischemic stroke outcomes. MJ Reeves JW Gargano Z Luo AJ Mullard BS Jacobs A Majid Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators, Stroke 2008 39 1779 85 18369173
19. The effect of statin pretreatment on infarct volume in ischemic stroke. JS Nicholas CJ Swearingen JC Thomas Z Rumboldt P Tumminello SJ Patel, Neuroepidemiology 2008 31 48 56 18560243
20. Statins in ischemic stroke: just low-density lipoprotein lowering or more. LG Stead L Vaidyanathan G Kumar MF Bellolio RD Brown Jr S Suravaram S Enduri RM Gilmore WW Decker, J Stroke Cerebrovasc Dis 2009 18 124 7 19251188
21. Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial. LB Goldstein P Amarenco J Zivin M Messig I Altafullah A Callahan M Hennerici MJ MacLeod H Sillesen R Zweifler K Michael A Welch Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators, Stroke 2009 40 3526 353 19745172
22. PROspective Study of Pravastatin in the Elderly at Risk: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. J Shepherd GJ Blauw MB Murphy EL Bollen BM Buckley SM Cobbe I Ford A Gaw M Hyland JW Jukema AM Kamper PW Macfarlane AE Meinders J Norrie CJ Packard IJ Perry DJ Stott BJ Sweeney C Twomey RG Westendorp PROSPER study group, Lancet 2002 360 1623 30 12457784
23. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. LB Goldstein P Amarenco M Szarek A Callahan M Hennerici H Sillesen JA Zivin KM Welch SPARCL Investigators, Neurology 2008 70 2364 70 18077795
24. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. N Meier K Nedeltchev C Brekenfeld A Galimanis U Fischer O Findling L Remonda G Schroth HP Mattle M Arnold, Stroke 2009 40 1729 37 19265056
25. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. JA Tobert, Nat Rev Drug Discov 2003 2 517 26 12815379
26. Better outcome after stroke with higher serum cholesterol levels. C Vauthey GR de Freitas G van Melle G Devuyst J Bogousslavsky, Neurology 2000 23 1944 9
27. Influence of cholesterol on survival after stroke: retrospective study. AG Dyker CJ Weir KR Lees, BMJ 1997 314 1584 1588 9169402
28. Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction. P Amarenco, Neurology 2001 57 35 S44 11552053
29. The dynamics of statins: from event prevention to neuroprotection. P Amarenco MA Moskowitz, Stroke 2006 37 294 296 16410465
30. Simvastatin-induced prevention of the increase in TNF-alpha level in the acute phase of ischemic stroke. A Szczepaska-Szerej J Kurzepa J Wojczal Z Stelmasiak, Pharmacol Rep 2007 59 94 7 17377212
31. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. PM Ridker E Danielson FA Fonseca J Genest AM Gotto Jr JJ Kastelein W Koenig P Libby AJ Lorenzatti JG Macfadyen BG Nordestgaard J Shepherd JT Willerson RJ Glynn JUPITER Trial Study Group, Lancet 2009 373 1175 82 Epub 2009 Mar 28. 19329177
32. Low-dose of statin treatment improves cerebrovascular reactivity in patients with ischemic stroke: single photon emission computed tomography analysis. M Murakami S Fujioka Y Hirata J Kuratsu, J Stroke Cerebrovasc Dis 2008 17 16 22 18190816
33. Statin enhancement of collateralization in acute stroke. B Ovbiagele JL Saver S Starkman D Kim LK Ali R Jahan GR Duckwiler F Vĩuela S Pineda BS Liebeskind DS Liebeskind, Neurology 2007 68 2129 2131 17562834
34. The beneficial effect of statins treatment by stroke subtype. P Martínez-Snchez C Rivera-Ordá̃ez B Fuentes MA Ortega-Casarrubios L Idrovo E Díez-Tejedor, Eur J Neurol 2009 16 127 33 19049507
35. Discontinuation of statin therapy and clinical outcome after ischemic stroke. F Colivicchi A Bassi M Santini C Caltagirone, Stroke 2007 38 2652 17761916
36. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. J Shepherd SM Cobbe I Ford CG Isles AR Lorimer PW MacFarlane JH McKillop CJ Packard, N Engl J Med 1995 333 1301 1307 7566020
37. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions. R Collins J Armitage S Parish P Sleight R Peto, Lancet 2004 363 757 767 15016485
38. Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association and American Stroke Association. The Stroke Council, Stroke 2004 35 1023 15044812
39. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. RJ Adams G Albers MJ Alberts O Benavente K Furie LB Goldstein,, et al. Stroke 2008 39 1647 1652 18322260